Search filters

List of works by Arianna Palladini

Activated d16HER2 homodimers and SRC kinase mediate optimal efficacy for trastuzumab

scientific article published on 27 August 2014

Antimetastatic Activity of a Preventive Cancer Vaccine

scientific article (publication date: 15 November 2007)

Cancer Vaccines Co-Targeting HER2/Neu and IGF1R.

scientific article published on 11 April 2019

Endothelin-3 production by human rhabdomyosarcoma: a possible new marker with a paracrine role

scientific article published on 24 January 2006

Evolution of HER2-positive mammary carcinoma: HER2 loss reveals claudin-low traits in cancer progression

scientific article published in 2021

HER-2/neu tolerant and non-tolerant mice for fine assessment of antimetastatic potency of dendritic cell-tumor cell hybrid vaccines.

scientific article

High metastatic efficiency of human sarcoma cells in Rag2/gammac double knockout mice provides a powerful test system for antimetastatic targeted therapy.

scientific article published on 22 December 2009

Immune targeting of autocrine IGF2 hampers rhabdomyosarcoma growth and metastasis

scientific article published on 07 February 2019

In silico modeling and in vivo efficacy of cancer-preventive vaccinations.

scientific article

Inhibition of prostate carcinogenesis by combined active immunoprophylaxis

scientific article published on July 2007

Multiorgan metastasis of human HER-2+ breast cancer in Rag2-/-;Il2rg-/- mice and treatment with PI3K inhibitor

scientific article (publication date: 2012)

OX40 triggering concomitant to IL12-engineered cell vaccine hampers the immunoprevention of HER2/neu-driven mammary carcinogenesis

scientific article published on 11 June 2018

Opposing control of rhabdomyosarcoma growth and differentiation by myogenin and interleukin 4.

scientific article published in April 2009

Preclinical therapy of disseminated HER-2⁺ ovarian and breast carcinomas with a HER-2-retargeted oncolytic herpesvirus.

scientific article

Proteomic and PROTEOMEX profiling of mammary cancer progression in a HER-2/neu oncogene-driven animal model system.

scientific article published on November 2010

Tamoxifen combined to anti-HER-2/neu cell vaccine does not hamper cancer immunopreventive efficacy.

scientific article published on 31 January 2009

The Mechanisms of PD-L1 Regulation in Non-Small-Cell Lung Cancer (NSCLC): Which Are the Involved Players?

scientific article published on 26 October 2020

Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER2.

scientific article published on 23 January 2014

Virus-like particle display of HER2 induces potent anti-cancer responses

scientific article published on 5 January 2018